Investors Aroused as Pomerantz Investigates Abacus Management's Financial Practices
Pomerantz Law Firm Takes Action on Behalf of Abacus Investors
On July 7, 2025, Pomerantz LLP announced an investigation aimed at addressing claims made by investors against Abacus Global Management, Inc. (NASDAQ: ABL). This action comes in light of serious allegations surrounding the company's financial practices, raising the alarm among its investors regarding potential securities fraud.
Investigative Actions
The investigation is particularly focused on whether Abacus, along with some of its top executives and board members, has engaged in deceptive business practices or if they have violated any securities laws. Investors who feel they have been affected are encouraged to reach out to Pomerantz's Danielle Peyton for further assistance.
Concerns escalated on June 4, 2025, when Morpheus Research released a report questionable financial activities at Abacus. The document titled Abacus Global Management: This $794 Million SPAC Is Yet Another Life Settlements Accounting Scheme Manufacturing Fake Revenue By Systematically Underestimating When People Will Die triggered a drastic reaction in the market. It claimed that the company changed its portfolio valuation methods to present misleading profitability figures and raised red flags regarding the life expectancy estimates utilized within its operations. Consequently, Abacus's stock plummeted by $1.64, marking a decline of 21.47% to settle at $6.00 per share on June 5.
Company’s Response: A Call for Transparency
In an effort to quell investor fears, Abacus hired the independent actuarial firm Lewis Ellis to conduct a thorough evaluation of its financial integrity. The company's management sought to assure investors of its adherence to accounting regulations and to dispel the burgeoning accusations. However, matters intensified when Morpheus published additional claims on June 12, 2025, allegeing inconsistencies between Abacus's public disclosures and SEC filings. This report further alleged undisclosed related-party transactions and questionable practices among insiders known as
Topics Other）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.